ABSTRACT
INTRODUCTION
Transforming growth factor (TGF ) and other polypeptide growth factors play an important role in oncogenesis in multiple tissues (Sporn & Roberts 1985 , Keski-Oja et al. 1988 , Aaronson 1991 , Cross & Dexter 1991 , Dickson & Lippman 1995 , Ethier 1995 . TGF acts as a mitogen in most cell types and interacts with the transmembrane epidermal growth factor receptor to initiate intracellular signaling pathways (Derynck 1988) . TGF is expressed in multiple breast cancer cell lines and treatment of estrogen receptor (ER)-positive breast and endometrial cancer cell lines with 17 -estradiol (E2) induces TGF gene expression and/or protein secretion. Induction of TGF by E2 may be important for mediating the mitogenic effects of estrogen through paracrine and autocrine pathways (Bates et al. 1988 , Clarke et al. 1989 , Manni et al. 1990 , Gong et al. 1992 .
In transient transfection studies, E2 induces reporter gene activity using constructs containing 2813 to 5, 1565 to 5, and 1145 to 5 inserts from the TGF gene promoter (Saeki et al. 1991) . Constructs containing the more proximal region from this promoter ( 370 to 5 and 77 to 5) exhibited low basal activity and the sequences from 370 to 77 were required for transcriptional activation of TGF by E2 in MCF-7 cells (Saeki et al. 1991) . El-Ashry and coworkers (1996) recently identified a 53 bp sequence ( 252 to 200) in the TGF gene promoter containing two imperfect palindromic estrogen responsive elements (EREs) that bound ER .
Studies in this laboratory have been investigating the mechanisms of ER -mediated expression of several genes and their interactions with other regulatory pathways and receptors including the aryl hydrocarbon receptor (AhR) (Krishnan et al. 1995 , Safe 1995 , Gillesby et al. 1997 , Zacharewski & Safe 1998 ). Based on results of preliminary studies showing inhibitory AhR-ER crosstalk with TGF , we have further analyzed the 5 -flanking region of the TGF gene promoter to delineate trans-acting factors and genomic elements required for E2 responsiveness. Deletion analysis of the upstream region ( 1145 to 377) of the TGF gene promoter identified an E2-responsive sequence ( 625 to 549) containing three GC-rich sequences and a GGTAA imperfect ERE half-site (ERE½). Further analysis showed that E2-induced transactivation was associated with an ER /Sp1 complex interaction with an Sp1(N) 30 ERE½ motif in which both the Sp1 and ERE½ motif were required. Thus, the TGF gene promoter contains at least two functional enhancer sequences at 625 to 549 and 252 to 200 that are required for E2 responsiveness in MCF-7 cells.
MATERIALS AND METHODS

Chemicals and biochemicals
Recombinant human Sp1 protein was purchased from Promega Corp. (Madison, WI, USA). Pure recombinant ER human protein was purchased from Pan Vera (Madison, WI, USA). The TGF oligonucleotides were synthesized by the Gene Technologies Laboratory or the Institute for Developmental and Molecular Biology, Texas A&M University (College Station, TX, USA). Human ER antibody (C-314) and human Sp1 antibody (1C6) were purchased from Santa Cruz Biotech (Santa Cruz, CA, USA). All other chemicals and biochemicals were the highest quality available from commercial sources. Wild-type human (h) ER and mutant hE11 expression plasmid were kindly provided by Dr Pierre Chambon (Illkirch, France). The synthetic oligonucleotides used in this study are shown in Table 1 . The GC-rich sequences and ERE½ are underlined and mutations are noted with an asterisk.
Plasmids
The pTGF 1145/ 5 was kindly provided by Dr David S Salomon (National Cancer Institute, Bethesda, MD, USA). The pXP1 luciferase reporter vector was obtained from the American Type Culture Collection (Rockville, MD, USA). The TATA-luc construct was made in this laboratory by inserting an E1B TATA oligonucleotide into the pXP1 vector. The pTGF 1145/ 377, pTGF 1145/ 919, and pTGF 919/ 377 plasmids were made by ligation of the appropriate restriction fragments from pTGF 1145/ 5 into TATA-luc. Constructs containing synthetic oligonucleotides were made by annealing, phosphorylating, and cloning into TATA-luc.  1. The synthetic oligonucleotides used in this study. GC-rich sequences and ERE half-sites are underlined and mutations are noted with an asterisk Cell maintenance MCF-7 and MDA-MB-231 cells were obtained from the American Type Culture Collection. MCF-7 cells were grown in DME-F12 (Sigma Chemical Co., St Louis, MO, USA) supplemented with 2·2 g/l sodium bicarbonate, 10% fetal calf serum, and 10 ml/l antibiotic/antimycotic solution (Sigma). MDA-MB-231 cells were maintained in DME-F12 supplemented with 2·2 g/l sodium bicarbonate, 5% fetal calf serum, and 10 ml/l antibiotic/ antimycotic solution. All cells were grown in 150 cm 2 tissue culture dishes at 37 C in 5% CO 2 :95% air. For transfection experiments, MCF-7 cells were seeded onto 12-well tissue culture plates in DME-F12 without phenol red supplemented with 2·2 g/l sodium bicarbonate, 5% charcoalstripped fetal calf serum, and 10 ml/l antibiotic/ antimycotic solution, and MDA-MB-231 cells were seeded onto 12-well tissue culture plates in DME-F12 without phenol red supplemented with 2·2 g/l sodium bicarbonate, 2·5% charcoal-stripped fetal calf serum, and 10 ml/l antibiotic/antimycotic solution.
Transient transfection assay
Twenty-four hours after seeding, MCF-7 or MDA-MB-231 cells were transfected by the calcium phosphate method with 500 ng of the TGF -luciferase reporter constructs, 100 ng ER expression vector and 100 ng pCDNA3/His/lacZ (Invitrogen, Carlsbad, CA, USA) that was used as a standard reference control plasmid. After 20 h, media were removed and fresh DME-F12 without phenol red supplemented with 2·5% charcoalstripped fetal calf serum containing DMSO or 10 nM E2 in DMSO were added to the cells for 42 h. Cells were washed twice with PBS and harvested in 1 Reporter lysis buffer (Promega). Luciferase assays were performed on 20 µl cell extract using the Luciferase assay system (Promega). Light emission was detected on a Lumicount luminometer (Packard, Meriden, CT, USA). -Galactosidase assays were performed on 20 µl cell extract using the luminescent GalactonPlus assay kit (Tropix, Bedford, MA, USA). The experiments were carried out at least in triplicate and significance (P<0·05) was determined by Anova and Student's t-test.
Gel mobility shift assays
Oligonucleotides were annealed and end-labeled using T4-polynucleotide kinase and [ -32 P]ATP. Nuclear extracts from MCF-7 cells were prepared as described previously (Krishnan et al. 1995) . Gel shift reactions with nuclear proteins were carried out in 25 mM HEPES, 1·5 mM EDTA, 10% glycerol, 1·0 mM dithiothreitol (DTT), and 150 mM KCl in a final volume of 25 µl. Eight micrograms nuclear extracts from cells treated with DMSO or 10 nM E2 for 2 h were incubated with 1 µg polydeoxyinosinic-deoxycytidylic acid for 15 min at 25 C to bind nonspecific DNA binding proteins. After addition of 32 P-labeled DNA, the mixture was incubated for 15 min at 25 C. For competition assays, excess specific or nonspecific competitor oligo DNA was added (100-to 1000-fold) 5 min before the addition of 32 P-labeled DNA. Reaction mixtures were loaded onto a 5% polyacrylamide gel and run at 110 V in 0·9 M Tris, 0·9 M borate, 2 mM EDTA (pH 8·0). Gels were dried and protein-DNA complexes were visualized by autoradiography. For the supershift assays, ER antibody (C-134), Sp1 antibody (IC6) or normal mouse IgG was added to gel shift reactions as indicated and incubated for 20 min at 4 C. Extracts were then subjected to electrophoresis and detection as described above.
Schneider cell experiments
Drosophila Schneider's SL2 cells were maintained in Schneider's medium (Gibco BRL, Gaithersburg, MD, USA) supplemented with 10% heatinactivated fetal calf serum. SL2 cells were grown in 150-cm 2 tissue culture flasks in the dark at 22 C. SL2 cells were seeded onto 12-well tissue culture plates and transfected 24 h after seeding with 500 ng of the reporter construct and the indicated amounts of pPAC empty vector, pPAC/hER or pPAC/Sp1 (provided by R Tjian, University of California, Berkeley, CA, USA) expression plasmids. After transfection, cells were grown overnight and then dosed with 10 nM E2 without changing the medium. Cells were allowed to grow an additional 6 h and then harvested in 1 Reporter lysis buffer (Promega). Luciferase activity of the cell extracts was detected as described for the mammalian cells.
SssI footprinting
Ten nanograms pTGF 1145/ 5/luc linearized with HindIII were incubated with varying concentrations of MCF-7 nuclear extract treated with 10 nM E2 in 1 MS buffer (5% glycerol, 17·65 mM MgCl2, 0·18 mM S-adenosylmethionine, 5 mM DTT). Proteins were allowed to bind to the DNA for 5 min on ice followed by 20 min at 20 C. SssI (0·5 U, New England Biolabs, Beverly, MA, USA) was added to the reaction and incubated at 30 C for 15 min followed by heat inactivation for 15 min at 75 C. Following methylation, deamination and PCR amplification were carried out as previously described by Kladde and coworkers (1996) . PCR primers used were TGF A1b (AAAAACAAAAA ACACCTAACTTCAAAC) and TGF A2 (GGA TTATTTTTTTTGAGTTAAGTTTTGG).
RESULTS
Deletion analysis of the TGF gene promoter and transactivation studies in breast cancer cells
Initial studies showed that transfection of the TATA-luc (empty vector) or pXP1 vector alone or in combination with ER expression plasmid and 10 nM E2 did not result in induction of luciferase activity (Fig. 1A) . Moreover, hormone-induced transactivation of TGF 1145/ 5-luc was only observed after cotransfection with ER . In MCF-7 cells transiently transfected with pTGF 1145/ 5-luc and pTGF 1145/ 377-luc, E2 induced reporter gene activity confirming that the 1145 to 377 region of the TGF gene promoter was E2 responsive (Fig. 1B) . Further analysis of this gene promoter demonstrated that constructs containing the upstream region ( 1145 to 919) were not E2 responsive, whereas E2 induced luciferase activity in MCF-7 cells transfected with pTGF 919/ 377 and pTGF 625/ 549. The 77 bp sequence ( 625 to 549) contains three GC-rich Sp1 binding sites and an imperfect ERE½ (GGTAA) and this region of the TGF gene promoter was further analyzed using several deletion and mutant constructs (Fig. 1C) . Sequential mutation of the GC-rich sites and ERE½ motif (TGF mERE-luc) demonstrated that only the upstream (5 -) GC-rich binding site and the imperfect ERE½ motif were required for E2 responsiveness. Transcriptional activation of pTGF 625/ 549 by E2 was observed using wild-type ER in MCF-7 and MDA-MB-231 cells, whereas no induction was observed using variant hE11 containing deletions in the DNA binding domain (Fig. 1D) . These results suggest that DNA binding of ER is required for E2 activation.
 1. Analysis of the TGF gene promoter. MCF-7 cells were transiently transfected with several constructs including empty vectors (TATA-luc and pXP1) (A) and those containing TGF gene promoter inserts from 1145 to 5 (A, B), and wild-type and mutant constructs containing sequences from 625 to 549 (C). Luciferase activities were determined as described in Materials and Methods. Cells were cotransfected with wild-type hER , and treated with DMSO or 10 nM E2. (D) Effects of wild-type vs mutant ER . MDA-MB-231 breast cancer cells were transfected with pTGF 625/ 549 as described above; however, the comparative effects of wild-type (W.T.) vs variant (hE11) ER on E2 inducibility were determined. Results are expressed as means .. for at least 3 separate experiments for each treatment group. Significant induction (P<0·05) by E2 is indicated with an asterisk. RLU refers to units of relative luciferase activity.
Gel mobility shift assays
Protein binding to the 625/ 580 region of the TGF gene promoter that contains the active Sp1(N) 30 ERE½ motif was investigated by gel mobility shift assays using [ 32 P]TGF 625/ 580 and various proteins and MCF-7 nuclear extracts.
The results illustrated in Fig. 2A (Fig. 2B) to form an intense broad retarded band that is significantly decreased in intensity after coincubation with 200-to 1000-fold excess unlabeled Sp1 (lanes 3 through 5), 100-to 400-fold excess ERE (lanes 6 through 8) or 100-fold excess TGF 625/ 580 (lane 9) oligonucleotides. In contrast, competition with a non-specific xenobiotic response element (XRE) oligonucleotide (lane 10) did not decrease the intensity of the retarded band. Interaction of ER and Sp1 proteins with [ 32 P]TGF 625/ 580 was further investigated using nuclear extracts from MCF-7 cells treated with 10 nM E2 (Fig. 3, lane 1) , followed by incubation with antibodies to Sp1 (lanes 2 and 3) and ER (lane 4) proteins and nonspecific IgG (lane 5). Incubation with 5 µg Sp1 antibody gave a supershifted band (SS-band) (lane 3) and a second supershifted band with slightly higher mobility was observed after coincubation with ER antibody (lane 4). In contrast, coincubation with non-specific IgG did not result in formation of a supershifted complex. Figure 4 summarizes in vitro SssI DNA methylation footprinting of the 625 to 580 region of the TGF gene promoter (lane 1) and incubation with nuclear extracts from MCF-7 cells significantly enhanced binding (decreased methylation) at the ERE½ (lanes 2 and 3). Only minimal footprinting was observed at the GC-rich site; however, this decreased methylation was observed in replicate experiments.
In vitro SssI footprinting
Interactions of Sp1 and ER with pTGF 625/ 549, pTGF 625/ 549-mERE in Schneider SL2 cells
Schneider SL2 cells do not express Sp1 or ER proteins, and functional interactions of both transcription factors were investigated using constructs containing the 625/ 549 region of the TGF gene promoter. Cotransfection of TATAluc (empty vector) with Sp1 expression plasmid did not enhance luciferase activity, whereas a dosedependent response was observed using pTGF 625/ 549 (Fig. 5A) . In SL2 cells transfected with pTGF 625/ 549, ER expression plasmid  4. In vitro footprinting of the proximal region of the TGF gene promoter by SssI DNA methyltransferase-mediated methylation (Kladde et al. 1996) . A restriction fragment of the TGF gene promoter was incubated alone or in combination with nuclear extracts from MCF-7 cells, and DNAmethylation patterns in the 625 to 580 region were determined as described in Materials and Methods. Incubation with nuclear extracts markedly inhibited DNA methylation in the region of the ERE½ but only slight decreases in DNA methylation were observed at the GC-rich sequence (lanes 1-3, left to right).
(10 or 100 ng) plus pPAC (empty vector) increased luciferase activity and, in cotransfection studies (ER plus Sp1 expression plasmids), the response was essentially additive (Fig. 5B) . The role of the ERE½ site was investigated using pTGF 625/ 549-mERE (Fig. 5C) ; the results showed that ER expression plasmid alone did not increase luciferase activity, whereas expression of 50 ng Sp1 expression plasmid increased luciferase activity comparable to that observed using the wild-type construct (Fig. 5B) . Cotransfection of Sp1 and ER expression plasmids (using pTGF 625/ 549-mERE) gave results that were not significantly different from those observed with Sp1 alone. Previous studies using a construct containing two GC-rich sites from the bcl-2 gene promoter showed that cotransfection with Sp1 and ER expression plasmids gave enhanced (more than additive) transactivation , and the results in Fig. 5D using a construct containing three GC-rich sites also gave enhanced activity using ER and Sp1 expression plasmids. Thus, results obtained using pTGF 625/ 549 are consistent with both ER and Sp1 action in this region of the TGF gene promoter in which ER -ERE½ binding is required.
DISCUSSION
Growth of breast and endometrial tumors is dependent on multiple mitogenic factors including estrogenic hormones and polypeptide growth factors such as TGF . In many hormone-independent tumors, growth factors play an important autocrine and/or paracrine role in stimulating cancer cell proliferation (Sporn & Roberts 1985 , Keski-Oja et al. 1988 , Aaronson 1991 , Cross & Dexter 1991 , Dickson & Lippman 1995 , Ethier 1995 . Several studies have demonstrated that in E2-responsive breast and endometrial tumors, TGF gene expression and protein secretion are induced by E2 and TGF stimulates breast cancer cell growth via an endocrine-related autocrine loop (Bates et al. 1988 , Clarke et al. 1989 , Manni et al. 1990 , Gong et al. 1992 . Reddy and coworkers (1994) confirmed a linkage between E2/TGF and growth of T47D breast cancer cells using cells stably transfected with metallothionein promoter-dependent antisense TGF . E2 induced DNA synthesis and growth of stably transfected T47D cells; however, cotreatment with cadmium increased expression of antisense TGF mRNA and decreased hormone-induced mitogenic activity. The data confirmed results of an earlier study showing that antisense TGF mRNA oligonucleotide inhibited comparable E2-induced responses in breast cancer cells (Kenney et al. 1993) . Analysis of the TGF gene promoter has shown that an 1140 bp sequence ( 1145 to 5) conferred E2 responsiveness in transient transfection assays utilizing the 1145 to 5 promoter insert linked to a luciferase reporter gene (Fig. 1B) (Saeki et al. 1991) . E2 responsiveness was observed only after cotransfection of ER since levels of endogenous ER were not sufficient in cells that highly overexpress the promoter-reporter constructs. This has been observed in other studies with plasmids containing promoter inserts from other E2-responsive genes, including c-fos, progesterone receptor, cathepsin D, pS2, heat shock protein 27, E2F1, insulin-like growth factor binding protein-4, adenosine deaminase, and retinoic acid receptor (Cavailles et al. 1989 , Weisz & Rosales 1990 , Savouret et al. 1991 , Zacharewski et al. 1994 , Duan et al. 1998 , Sun et al. 1998 , Qin et al. 1999 , Xie et al. 1999 . Previous studies showed that E2-responsiveness of this promoter in MCF-7 cells was due, in part, to a 53 bp sequence ( 252 to 200) containing two imperfect palindromic EREs (El-Ashry et al. 1996) . However, further analysis ( Fig. 1) showed that upstream promoter sequences ( 1145 to 377) also contribute to E2 responsiveness of TGF . This region of the TGF gene promoter contains multiple AP-1 and Sp1 protein binding sites and ERE half-sites, and E2 responsiveness was associated with a 77 bp region ( 625 to 549) containing three GC-rich Sp1 binding sites and an ERE half-site (Fig. 1C) .
E2-dependent transactivation via ER /Sp1 interactions have been characterized in promoters of several E2-responsive genes, including creatine kinase B, c-myc, cathepsin D, heat shock protein 27, c-fos, retinoic acid receptor 1, E2F1, adenosine deaminase, insulin-like growth factor binding protein 4 and bcl-2 (Dubik & Shiu 1992 , Krishnan et al. 1994 , Rishi et al. 1995 , Porter et al. 1996 , Duan et al. 1998 , Sun et al. 1998 , Wang et al. 1998 , Qin et al. 1999 , Xie et al. 1999 . Both ER and Sp1 proteins physically interact (Porter et al. 1997) ; however, transactivation is mediated by at least two pathways, namely (i) interaction of ER /Sp1 proteins with GC-rich genomic sites in which only Sp1 protein binds DNA and (ii) interaction of ER /Sp1 with Sp1(N) x ERE half-site motifs in which both proteins bind DNA. Mutational analysis of the three GC-rich sites within pTGF 625/ 549 (Fig. 1C) showed that the upstream GC-rich site was required for E2 responsiveness since no induction was observed after mutation of this site (pTGF 625/ 549-m1). Mutation of the downstream (5 -) GC-rich sites within this region did not affect E2 responsiveness. Previous studies showed that ER/Sp1 action through binding to GC-rich sites can be observed in MCF-7 or ER-negative MDA-MB-231 cells cotransfected with wild-type ER or mutant hE11 that does not contain the DNA binding domain (Duan et al. 1998 , Sun et al. 1998 , Qin et al. 1999 , Xie et al. 1999 . However, E2 induced luciferase activity in MDA-MB-231 cells transfected with pTGF 625/ 549 plus wild-type hER expression plasmid but not variant hE11 expression plasmid (Fig. 1D) , suggesting that Sp1 binding alone was not sufficient for ER action. Mutation of the ERE half-site (pTGF 625/ 459-mERE) also resulted in loss of transcriptional activation by E2 (Fig. 1C) . This result suggests that the Sp1(N) 30 ERE half-site motif was a functional E2 enhancer sequence and that ER may be interacting with ERE½ as a monomer. It is possible that more than one GCrich site within the 625 to 549 region of the promoter may contribute to ER /Sp1 action.
Interactions of ER /Sp1 with Sp1(N) x ERE half sites have previously been analyzed by gel mobility shift assays to give a broad retarded band that binds both proteins but does not exhibit the expected supershifted band (Krishnan et al. 1994 , Rishi et al. 1995 , Porter et al. 1996 (Figs 2 and 3) , and since the retarded band was observed only with nuclear extracts and not with recombinant ER plus Sp1 proteins, it is likely that other endogenous nuclear factors are required for ER /Sp1-DNA complex formation. In vitro SssI methylation footprinting, a highly sensitive assay for detecting protein-DNA interactions (Kladde et al. 1996 , was also used to investigate protein interactions with the Sp1(N) 30 ERE½ motif in the TGF gene promoter (Fig. 4) . Three major methylated bands were observed in the 625 to 580 region and, in the presence of nuclear extracts from MCF-7 cells (treated with E2), methylation at the ERE½ was decreased and a small but consistent decrease was also observed at the GC-rich site. Thus, in vitro footprinting in the 625 to 580 region of the TGF gene promoter was consistent with the gel mobility shift results and was similar to results of in vivo footprinting of the 304 to 207 region of the uteroglobin gene promoter which also contains ERE and GC-rich motifs required for E2 action (Scholz et al. 1998) .
Interactions of ER and Sp1 proteins with a GC-rich region of the bcl-2 gene promoter (two Sp1 binding sites) showed that cotransfection of ER plus Sp1 expression plasmids resulted in enhanced transactivation in Schneider SL2 cells . Similar results were observed in this study (Fig. 5D ) using a plasmid containing a promoter insert with three consensus GC-rich sites. A recent report also showed that transcriptional activation of the vitellogenin A1 io gene promoter by E2 in Drosophila-derived SL2 cells involved enhanced or synergistic interactions between ER and Sp1 bound to ERE and GC-rich sites that are separated by >1000 bp (Batistuzzo de Medeiros et al. 1997) . In contrast, our results with pTGF 625/ 549 and ERE½ mutant constructs showed that both GC-rich and ERE½ sites were required for ER /Sp1 action and their interactions were essentially additive (Fig. 5) . These results were similar to deletion/mutant analysis of the TGF gene promoter in breast cancer cells (Fig. 1) but do not exclude a role for unknown nuclear factors in mammalian cells required for enhanced ER /Sp1 interactions at Sp1(N) x ERE½ motifs that are not expressed in SL2 cells.
Thus, hormone-inducibility via ER /Sp1 action is highly complex and involves GC-rich ERE½ and ERE motifs in multiple configurations that are promoter dependent (Fig. 6) . Moreover, ER /Sp1 functionality may also depend on the cell context, and ongoing studies in this laboratory are investigating promoter-and cell-specific ER /Sp1 activation of several gene promoter constructs, including TGF .
